Makishima, Hideki
Shinshu University Faculty of Medicine,
Japan
2025 Rank: 126,606
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,282 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126,606 | 125,297 |
| Total Cites | 843 | 956 |
| H-index | 15 | 16 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 123 | 138 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 156 | 174 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 667 | 741 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
11.82%
|
|
Makishima, Hideki
Kyoto University,
Japan
2024 Rank: 92,173
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,808 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,173 | 88,852 |
| Total Cites | 896 | 1,027 |
| H-index | 16 | 17 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 111 | 129 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 151 | 171 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 721 | 794 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
12.76%
|
|
Makishima, Hideki
Kyoto University,
Japan
2023 Rank: 131,605
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,709 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131,605 | 132,659 |
| Total Cites | 947 | 1,094 |
| H-index | 15 | 16 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 85 | 96 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 128 | 140 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 734 | 821 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
13.44%
|
|
Makishima, Hideki
Graduate School of Medicine,
Japan
2022 Rank: 83,069
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,004 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83,069 | 82,252 |
| Total Cites | 1,038 | 1,203 |
| H-index | 17 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 3 | 4 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 122 | 133 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 190 | 205 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 777 | 865 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
13.72%
|
|
Makishima, Hideki
Graduate School of Medicine,
Japan
2021 Rank: 90,484
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,016 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90,484 | 85,260 |
| Total Cites | 1,348 | 1,617 |
| H-index | 19 | 21 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 167 | 192 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 253 | 288 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,037 | 1,171 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.38 |
| Self-Citation Percentage |
16.64%
|
|
Makishima, Hideki
Kyoto University,
Japan
2020 Rank: 105,347
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,130 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105,347 | 104,137 |
| Total Cites | 920 | 1,091 |
| H-index | 16 | 17 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 120 | 139 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 167 | 193 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 726 | 817 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.34 |
| Self-Citation Percentage |
15.67%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.